Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome-Reference-Cited by-同舟云学术

Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome

Published:2017-09 Issue:2 Volume:1 Page:185-191
ISSN:2542-4548
Container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
language:en
Short-container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Author:

Qureshi Muhammad Y.,Cabalka Allison K.,Khan Shakila P.,Hagler Donald J.,Haile Dawit T.,Cannon Bryan C.,Olson Timothy M.,Cantero-Peral Susana,Dietz Allan B.,Radel Darcie J.,Taggart Nathan W.,Kelle Angela M.,Rodriguez Vilmarie,Dearani Joseph A.,O’Leary Patrick W.,Nelson Timothy J.,Cavanaugh Karen M.,Miller Jennifer M.,Miller Karen S.

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Heart transplantation after Fontan: results from a surgical Fontan cohort;Pundi;Pediatr Transplant,2016

2. Transcoronary transplantation of progenitor cells after myocardial infarction;Assmus;N Engl J Med,2006

3. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI);Assmus;Circulation,2002

4. Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study

5. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging;Britten;Circulation,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-based therapy to boost right ventricular function and cardiovascular performance in hypoplastic left heart syndrome: Current approaches and future directions;Seminars in Perinatology;2023-04

2. Current state of the art in hypoplastic left heart syndrome;Frontiers in Cardiovascular Medicine;2022-10-28

3. Placenta as a source for progenitor cells for cardiac cell-based therapies;Applications in Engineering Science;2022-09

4. Management of externally manufactured cell therapy products: the Mayo Clinic approach;Cytotherapy;2022-01

5. Sensitive detection of integrated and free transcripts in chimeric antigen receptor T-cell manufactured cell products using droplet digital polymerase chain reaction;Cytotherapy;2021-05